BHR Relative Valuation
BHR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BHR is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for BHR's competitors is 2.31, providing a benchmark for relative valuation. Braemar Hotels & Resorts Inc Corp (BHR) exhibits a P/S ratio of 0.20, which is -91.34% above the industry average. Given its robust revenue growth of -1.49%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
GLSI
Greenwich Lifesciences Inc
10.180
USD
+4.52%
LXEO
Lexeo Therapeutics Inc
3.290
USD
+1.54%
LYEL
Lyell Immunopharma Inc
0.413
USD
-0.48%
VXRT
Vaxart Inc
0.500
USD
-0.99%
ACTU
Actuate Therapeutics Inc
10.260
USD
-2.75%
NEGG
Newegg Commerce Inc
6.170
USD
-0.48%
ALEC
Alector Inc
1.270
USD
+4.10%
JYNT
Joint Corp
10.060
USD
-0.49%
MHH
Mastech Digital Inc
7.350
USD
-9.26%
BDSX
Biodesix Inc
0.301
USD
0.00%
FAQ
Is Braemar Hotels & Resorts Inc (BHR) currently overvalued or undervalued?
Braemar Hotels & Resorts Inc (BHR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.20 is considered Undervalued compared with the five-year average of 0.41. The fair price of Braemar Hotels & Resorts Inc (BHR) is between 7.76 to 10.58 according to relative valuation methord. Compared to the current price of 2.13 USD , Braemar Hotels & Resorts Inc is Undervalued By 72.54% .
What is Braemar Hotels & Resorts Inc (BHR) fair value?
How does BHR's valuation metrics compare to the industry average?
What is the current P/B ratio for Braemar Hotels & Resorts Inc (BHR) as of May 20 2025?
What is the current FCF Yield for Braemar Hotels & Resorts Inc (BHR) as of May 20 2025?
What is the current Forward P/E ratio for Braemar Hotels & Resorts Inc (BHR) as of May 20 2025?